Next, we demonstrated that MSI-H CRC patients with increased IL2RB+ immune cells have an increased abundance of CD3, CD4 and FOXP3 TILs and higher PDL1 tumor and ICOS expression. This evidence concerns the gene CD4 and neoplasm.